Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enlivex Ltd (ENLV)

Enlivex Ltd (ENLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 284,858
  • Shares Outstanding, K 237,382
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,010 K
  • EBIT $ -15 M
  • EBITDA $ -14 M
  • 60-Month Beta 1.55
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.53

Options Overview Details

View History
  • Implied Volatility 270.77% (-104.40%)
  • Historical Volatility 74.12%
  • IV Percentile 22%
  • IV Rank 18.58%
  • IV High 1,261.57% on 12/09/25
  • IV Low 44.60% on 12/18/25
  • Expected Move (DTE 22) 0.4250 (38.99%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 138
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 950
  • Open Int (30-Day) 1,325
  • Expected Range 0.6650 to 1.5150

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +93.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0150 +7.39%
on 03/20/26
1.3200 -17.42%
on 03/25/26
-0.0600 (-5.22%)
since 02/26/26
3-Month
0.6600 +65.15%
on 12/31/25
1.3200 -17.42%
on 03/25/26
+0.3423 (+45.78%)
since 12/26/25
52-Week
0.6600 +65.15%
on 12/31/25
2.1000 -48.10%
on 08/15/25
+0.0400 (+3.81%)
since 03/26/25

Most Recent Stories

More News
Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / March 20, 2026 / RedChip Companies will air interviews with Off The Hook YS Inc. (NYSE American:OTH) and Enlivex Ltd. (NASDAQ:ENLV) on the RedChip Small Stocks, Big Money™...

OTH : 2.16 (-9.24%)
ENLV : 1.0900 (-9.17%)
RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance

ORLANDO, FL / ACCESS Newswire / February 9, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced that on-demand...

MMA : 0.4711 (+9.61%)
ENLV : 1.0900 (-9.17%)
BGL : 1.1100 (-6.72%)
OWLS : 5.91 (-2.15%)
IPST : 0.2800 (-13.21%)
RedChip Spotlights the Future of Finance at Fintech & Digital Asset Treasury Strategy (DATS) Virtual Investor Conference on February 4

ORLANDO, FLORIDA / ACCESS Newswire / January 27, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming...

MMA : 0.4711 (+9.61%)
ENLV : 1.0900 (-9.17%)
BGL : 1.1100 (-6.72%)
OWLS : 5.91 (-2.15%)
Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors

Enlivex Announced today $212,000,000 private placement to initiate world's first prediction markets digital asset treasury strategy, via RAIN token accumulation

ENLV : 1.0900 (-9.17%)
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / October 3, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Lantern Pharma, Inc. (Nasdaq:LTRN) on the RedChip Small Stocks,...

ENLV : 1.0900 (-9.17%)
LTRN : 2.09 (-5.86%)
Home Sales Stateside, Canada GDP Due Next Week

Monday U.S. Economic Lookahead New home sales (July) Featured Earnings PDD ...

NVDA : 171.24 (-4.16%)
BEKE : 15.32 (-2.54%)
FRO : 33.57 (-0.53%)
CRWD : 392.62 (+1.75%)
SNOW : 162.33 (+1.07%)
ADSK : 239.83 (+1.87%)
MDB : 241.28 (-2.13%)
OKTA : 79.38 (+1.61%)
HEI : 272.64 (-2.31%)
NSSC : 38.92 (-6.22%)
JKS : 25.52 (-3.66%)
ENLV : 1.0900 (-9.17%)
Enlivex Therapeutics and Foremost Clean Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / June 13, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics (NASDAQ:ENLV) and Foremost Clean Energy (Nasdaq:FMST) on the RedChip Small Stocks, Big Money™...

ENLV : 1.0900 (-9.17%)
FMST : 1.6800 (-6.67%)
FAT.CN : 2.3500 (-6.37%)
RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis

Unlock AI-powered insights for data-driven precision and real-time efficiency

ENLV : 1.0900 (-9.17%)
ASPI : 4.61 (-8.53%)
BFRG : 0.5420 (-1.99%)
NVA : 5.52 (-5.15%)
GRRR : 10.46 (-3.68%)
The Trump Effect: Crypto Diversification Accelerates Across Industries

Issued on behalf of Spearmint Resources Inc. VANCOUVER – USA News Group – With the upcoming inauguration of US President Re-Elect Donald Trump on the horizon, several businesses are diversifying...

MSTR : 132.93 (-4.46%)
TSLA : 372.11 (-3.59%)
ENLV : 1.0900 (-9.17%)
SPMTF : 0.0560 (+18.64%)
SPMT.CN : 0.0050 (-33.33%)
^BTCUSDT : 68,767.80 (-0.31%)
HOTH : 0.8389 (-6.65%)
^BTCUSD : 68,752.26 (-0.29%)

Business Summary

Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome)...

See More

Key Turning Points

3rd Resistance Point 1.2367
2nd Resistance Point 1.2033
1st Resistance Point 1.1467
Last Price 1.0900
1st Support Level 1.0567
2nd Support Level 1.0233
3rd Support Level 0.9667

See More

52-Week High 2.1000
Fibonacci 61.8% 1.5499
Fibonacci 50% 1.3800
Fibonacci 38.2% 1.2101
Last Price 1.0900
52-Week Low 0.6600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.